Ash Biotech

Biotechnology Research • United Kingdom • 1-10 Employees

Company overview

Headquarters	United Kingdom
Website	ashbiotech.com
SIC	873
Employees	1-10

Key Contact at Ash Biotech

Nahaku Smith

CEO

Ash Biotech Email Formats

Ash Biotech uses 1 email format. The most common is {first initial} (e.g., j@ashbiotech.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@ashbiotech.com	100%

About Ash Biotech

Ash Biotech is focused on enabling enhanced understanding and more informed decision-making in determining the efficacy and safety of potential new drugs; and on finding new uses for "old" or "failed" drugs, through the use of its proprietary "phenotype-based" drug discovery technologies. The company was founded by European Biotech industry leaders who have pioneered: ultra high-throughput screening of small-molecule drugs; high-throughput screening of antibody drugs; and who played important roles in the establishment of antibody drugs as the world's most important new class of drugs. The founders have played key roles in growing biotech/pharma companies in Europe and the US to a combined exit values of over two and a half billion dollars. The company is privately held, and is located in Cambridge UK. The has been developing its platform technology for the last four years, and will be revealing details of its technology, and its initial product offering, during the first quarter of 2010. If you would like us to let you know when we release more details, please send an email to news@ashbiotech.com and we'll keep you informed.

Ash Biotech revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding